CRISPR Therapeutics Free Cash Flow (Quarterly) Insights

CRISPR Therapeutics AG (CRSP)

55.63 -1.33 (-2.33%) USD | NASDAQ | May 16, 16:00

55.99 +0.36 (+0.65%) After-Hours: 20:00

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2016. Upgrade now.

Date	Value
March 31, 2024	109.03M
December 31, 2023	-96.81M
September 30, 2023	-42.97M
June 30, 2023	-138.30M
March 31, 2023	5.74M
December 31, 2022	-119.52M
September 30, 2022	-111.24M
June 30, 2022	-151.59M
March 31, 2022	-150.59M
December 31, 2021	-95.22M
September 30, 2021	-118.38M
June 30, 2021	778.55M
March 31, 2021	-107.69M
December 31, 2020	-87.45M
September 30, 2020	-81.22M
June 30, 2020	-32.88M
March 31, 2020	-55.17M

Date	Value
December 31, 2019	2.424M
September 30, 2019	130.96M
June 30, 2019	-38.56M
March 31, 2019	-44.83M
December 31, 2018	-29.37M
September 30, 2018	-20.66M
June 30, 2018	-25.74M
March 31, 2018	-23.24M
December 31, 2017	-15.05M
September 30, 2017	-18.86M
June 30, 2017	-17.30M
March 31, 2017	-26.70M
December 31, 2016	-17.19M
September 30, 2016	-13.78M
June 30, 2016	-14.65M
March 31, 2016	-10.25M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-151.59M

Minimum

Jun 2022

778.55M

Maximum

Jun 2021

-20.04M

Average

-84.34M

Median

Free Cash Flow (Quarterly) Benchmarks